Program

Dr. Patrick Harrington, Ph.D. is a Clinical Microbiology Reviewer at the U.S. Food and Drug Administration, Center Drug Evaluation and Research, Division of Antiviral Products, in Silver Spring, MD. He is a virologist by training, with research experience with RNA viruses and HIV/SIV. He analyzes non-clinical and clinical virology data, reviews study protocols, and provides ...
Read more

Jane McKeating, PhD. Professor of Molecular Virology, University of Birmingham, UK. Jane’s research has focused on the mechanism of viral glycoprotein-receptor interactions required for particle entry, having published over 100 peer-reviewed articles in this area. Jane completed her PhD on cytomegalovirus at University College London in 1985. Since then she studied human immunodeficiency virus interaction with cells of the ...
Read more

Robert H. Silverman, Ph.D. is Mal and Lea Bank Chair and Professor at the Cleveland Clinic Lerner College of Medicine (Cancer Biology), at Case Western Reserve University (Biochemistry and Molecular Biology & Microbiology) and Cleveland State University (Chemistry). Dr. Silverman received his B.Sc. from Michigan State University and his Ph.D. in Molecular, Cellular and Developmental Biology from Iowa State ...
Read more

Mark S. Sulkowski, MD is an Associate Professor of Medicine and serves as the Medical Director of the Viral Hepatitis Center in the Divisions of Infectious Diseases and Gastroenterology/Hepatology at the Johns Hopkins University School of Medicine in Baltimore, Maryland. He received his MD from Temple University School of Medicine, Philadelphia, PA (1992), and completed his Fellowship in ...
Read more

Dr. Bambang S. Adiwijaya, Ph. D., is a Senior Pharmacometrician of Vertex Pharmaceuticals, Inc., Cambridge, MA, where he focuses on developing computational models of HCV disease and treatments. His main interest involves the applications of advanced computational tools to guide drug development, in particular, in the interface between ...
Read more

Dwight DuBois, MD, is the President and Laboratory Director of Cenetron Diagnostics and Cenetron Central Laboratories, based in Austin, Texas, USA. Dr. DuBois received his MD degree from the University of Texas (San Antonio), and completed a residency in Internal Medicine at Case-Western Reserve University, followed by a NIH-sponsored fellowship in Infectious Diseases at the University of Washington. Dr. DuBois founded ...
Read more

Dr. Stuart C. Ray, M.D. Associate Professor of Medicine, Johns Hopkins University (JHU) School of Medicine, Baltimore, MD USA. Dr. Ray's laboratory research is focused on understanding the genomic sequence variation hepatitis viruses, particularly hepatitis C virus, in the context of the host immune response and disease pathogenesis. Dr. Ray graduated from Vanderbilt University ...
Read more

David N. Standring, Ph.D., is Executive Vice President, Biology at Idenix Pharmaceuticals and has had roles of increasing responsibility since joining Idenix as Executive Director, Research in September 2000. Prior to joining Idenix, Dr. Standring led HBV and HCV programs at Schering Plough from 1998 to 2000 and at Bristol-Myers Squibb from 1994 to 1998. From 1984 to 1994, Dr. Standring was on the faculty of the University of California at San Francisco where his laboratory elucidated ...
Read more